Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA approves Adakveo to reduce vaso-occlusive crises in patients with sickle cell disease

Nov. 18, 2019

FDA grants accelerated approval to Brukinsa for mantle cell lymphoma

Nov. 15, 2019

FDA approves Fetroja for complicated urinary tract infections

Nov. 15, 2019

European Commission grants conditional marketing authorization to Ebola Zaire vaccine Ervebo

Nov. 12, 2019

FDA approves Reblozyl for anemia in beta thalassemia requiring regular RBC transfusions

Nov. 11, 2019

FDA approves Talicia for treatment of H. pylori in adults

Nov. 5, 2019

Oligomannate approved in China for mild to moderate AD

Nov. 4, 2019

FDA approves Vumerity for the treatment of multiple sclerosis

Oct. 31, 2019

FDA approves Baxdela for community-acquired bacterial pneumonia

Oct. 25, 2019

FDA approves Botox for pediatric patients with lower limb spasticity

Oct. 25, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...